Acuitas partners locally and globally with companies, academic institutes and other organizations to improve human health.
- Partnerships with companies developing new therapeutics to address unmet clinical needs
- Partnerships with academic researchers and governmental agencies to advance our understanding of delivery systems and novel therapeutic modalities
- Partnerships with local organizations to promote a healthy lifestyle by encouraging youth participation in sport
Acuitas has developed a broad IP portfolio focussed on the use of LNP technology for nucleic acid therapeutics. This portfolio primarily encompasses novel compositions of matter but also includes novel uses of nucleic acids therapeutics.
We have a strong track record of successfully working with partners to advance products to the clinic and to the marketplace.